Conference News

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today announced that four abstracts highlighting clinical progress across its botensilimab and balstilimab immunotherapy programs have been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2025, taking place in Berlin, Germany from October 17-21. The highlight is an oral presentation that will feature emerging survival plateaus from a study of botensilimab plus balst...

LOS ANGELES--(BUSINESS WIRE)--Hope Bancorp, Inc. (NASDAQ: HOPE) today announced that executive management will be participating in the 26th Annual KBW Community Bank Investor Conference in New York City, July 29, 2025. A copy of the investor presentation being used for meetings with institutional investors will be available in the Investor Relations section of the Company’s website at www.ir-hopebancorp.com effective July 25, 2025. About Hope Bancorp, Inc. Hope Bancorp, Inc. (NASDAQ: HOPE) is t...

BARCELONA, Spain--(BUSINESS WIRE)--Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results for the first half of 2025. The company continued to deliver strong sales growth in H1 2025, primarily driven by its dermatology business in Europe. Total Net Sales increased by 12.7% to €560.5 million, while EBITDA increased by 16.6% year-on-year to €121.8 million driven by higher sales growth and a gross profit of 65.5%. The European dermatology...

WILMINGTON, Del.--(BUSINESS WIRE)--Data for Incyte's TGFβR2×PD-1-directed Bispecific Antibody (INCA33890) and Selective Inhibitor of G12D-mutated KRAS (INCB161734) Accepted at ESMO 2025...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3rd, 2025. Management will participate in a Fireside Chat at 11:50 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available ap...

NEW YORK--(BUSINESS WIRE)--Zeta Global Announces Second Zeta Live 2025 Keynote: Serena Williams, Professional Athlete and Entrepreneur...

SAN FRANCISCO--(BUSINESS WIRE)--Twilio (NYSE: TWLO), the customer engagement platform that drives real-time, personalized experiences for today’s leading brands, today announced it has been recognized as a Leader in the 2025 Gartner® Magic Quadrant™ for Communications Platform as a Service CPaaS for its CPaaS platform1 for the third consecutive year2. The evaluation was based on specific criteria that analyzed the company’s overall Completeness of Vision and Ability to Execute. Twilio delivers...

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best will host a market briefing on the state of the captive insurance industry on Wednesday, Aug. 6, 2025, at 3:00 p.m. EDT. The event will feature a panel of AM Best senior analytical staff and industry experts for a conversation about the increasing permeation of the single parent captive and commercial market alternative segment across the overall insurance industry spectrum. Please click here to register for the Best’s Briefing, titled, “Captives: Continu...

SANTA ROSA, Calif.--(BUSINESS WIRE)--Keysight Technologies, Inc. (NYSE: KEYS) showcased its Open RAN leadership in collaboration with global industry partners during the O-RAN Alliance Spring 2025 Global PlugFest. O-RAN Global PlugFests, co-sponsored by the O-RAN ALLIANCE, aim to accelerate Open RAN development through comprehensive testing and integration. The Spring 2025 event ran from February through May across 19 labs in Asia, Europe, and North America, organized around themes designed to...

PITTSBURGH--(BUSINESS WIRE)--Plexision, a biotechnology company, today announced a $365,000 investment from the Richard King Mellon Foundation. The funds will be used to accelerate the integration of artificial intelligence (AI) and machine learning (ML) capabilities across Plexision’s suite of cell-based blood tests, significantly improving predictive accuracy for complex transplant outcomes. Despite advances in transplant medicine, managing immunosuppressive drugs remains a delicate balance....